These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 688286)

  • 41. Phase II evaluation of vindesine in patients with advanced colorectal carcinoma.
    Carroll DS; Gralla RJ; Kemeny NE
    Cancer Treat Rep; 1979; 63(11-12):2097-8. PubMed ID: 526944
    [No Abstract]   [Full Text] [Related]  

  • 42. [Sequential methotrexate and fluorouracil in metastasizing colorectal carcinomas. Results of a phase II pilot study (author's transl)].
    Herrmann R; Manegold C; Holzmann K; Fritze D
    Dtsch Med Wochenschr; 1982 Apr; 107(13):491-3. PubMed ID: 7060484
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phase I-II study of ftorafur and methyl-CCNU in advanced colorectal cancer.
    Belt RJ; Stephens R
    Cancer; 1979 Sep; 44(3):869-72. PubMed ID: 383275
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A controlled study of 5-fluorouracil versus 5-fluorouracil and methyl-CCNU in advanced gastrointestinal adenocarcinoma.
    Abdallah AM; Soukop M; Bell G; Calman KC
    Clin Oncol; 1977 Sep; 3(3):247-57. PubMed ID: 334430
    [No Abstract]   [Full Text] [Related]  

  • 45. High-dose melphalan, misonidazole, and autologous bone marrow transplantation for the treatment of metastatic colorectal carcinoma. A phase I study.
    Spitzer TR; Lazarus HM; Creger RJ; Berger NA
    Am J Clin Oncol; 1989 Apr; 12(2):145-51. PubMed ID: 2650527
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methyl-CCNU and methotrexate therapy in patients with advanced colorectal cancer after failure of 5-fluorouracil chemotherapy.
    Zorzitto ML; Myers R; Bazos MJ; Shepherd FA; Evans WK
    Am J Clin Oncol; 1986 Feb; 9(1):27-30. PubMed ID: 3953490
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phase II study of methyl-CCNU, vincristine, 5-fluorouracil, and streptozotocin in advanced colorectal cancer. By the Gastrointestinal Tumor Study Group.
    J Clin Oncol; 1984 Jul; 2(7):770-3. PubMed ID: 6234380
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A controlled prospective trial of adjuvant razoxane in resectable colorectal cancer.
    Gilbert JM; Cassell PC; Ellis H; Wastell C; Hellmann K; Evans MG; Stoodley BJ
    Recent Results Cancer Res; 1981; 79():48-58. PubMed ID: 7029684
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phase II clinical trial of ftorafur in 5-fluorouracil-refractory colorectal cancer.
    Buroker T; Miller A; Baker L; McKenzie M; Samson M; Vaitkevicius VK
    Cancer Treat Rep; 1977 Nov; 61(8):1579-80. PubMed ID: 336199
    [No Abstract]   [Full Text] [Related]  

  • 50. Iv methyl-CCNU and ftorafur with or without methanol-extracted residue of BCG for metastatic adenocarcinoma of the colon.
    Diggs CH; Wiernik PH; Smyth AC
    Cancer Treat Rep; 1977 Nov; 61(8):1581-3. PubMed ID: 336200
    [No Abstract]   [Full Text] [Related]  

  • 51. Combination chemotherapy with 5-fluorouracil and methyl-CCNU for the treatment of advanced gastrointestinal cancer.
    Brutti A; Liberati AM; Biscottini B; Fatati G; Sini S; Barzi AM; Grignani F
    Tumori; 1979 Jun; 65(3):339-44. PubMed ID: 462584
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Methyl-CCNU, 6-thioguanine, and 5-fluorouracil in advanced colorectal cancer.
    Aroney RS; Dalley DN; Chan WK; Bell DR; Levi JA
    Med Pediatr Oncol; 1981; 9(2):181-6. PubMed ID: 7231364
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lack of effectiveness of combined 5- fluorouracil and methyl-CCNU therapy in advanced colorectal cancer.
    Lokich JJ; Skarin AT; Mayer RJ; Frei E
    Cancer; 1977 Dec; 40(6):2792-6. PubMed ID: 589555
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison.
    Moertel CG; Fleming TR; Creagan ET; Rubin J; O'Connell MJ; Ames MM
    N Engl J Med; 1985 Jan; 312(3):137-41. PubMed ID: 3880867
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combination chemotherapy containing semustine (MeCCNU) in patients with advanced colorectal cancer previously treated with 5-fluorouracil (5-Fu).
    Engstrom PF; MacIntyre JM; Douglass HO; Muggia F; Mittelman A
    Am J Clin Oncol; 1983 Apr; 6(2):175-80. PubMed ID: 6829492
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Phase II study of the water-soluble nitrosourea compound ACNU in advanced colorectal carcinomas].
    Fiebig HH; Wellens W; Peukert M; Henss H; Arnold H; Westerhausen M; Löhr GW
    Onkologie; 1984 Dec; 7(6):370-7. PubMed ID: 6396565
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A randomized study of two different schedules of methyl CCNU, 5-FU and vincristine for metastatic colorectal carcinoma.
    Kemeny N; Yagoda A; Braun D; Golbey R
    Cancer; 1979 Jan; 43(1):78-82. PubMed ID: 367575
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phase II study of 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine in advanced colorectal carcinoma.
    Kemeny N; Yagoda A; Burchenal JH
    Cancer Treat Rep; 1978 Mar; 62(3):463-4. PubMed ID: 77190
    [No Abstract]   [Full Text] [Related]  

  • 59. A randomized clinical trial of combination chemotherapy in advanced colorectal cancer.
    O'Connell MJ; Schutt AJ; Moertel CG; Rubin J; Hahn RG; Scott M
    Am J Clin Oncol; 1987 Aug; 10(4):320-4. PubMed ID: 3303905
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phase II study of chromomycin A3 (NSC-58514) in advanced colorectal carcinoma.
    Moertel CG; Schutt AJ; Hahn RG; Marciniak TA; Reitemeier RJ
    Cancer Chemother Rep; 1975; 59(3):577-9. PubMed ID: 1203884
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.